Below is Scrip’s regular roundup, including information from Strategic Transactions , of recent technology transfer agreements between companies and academic or other research institutions. OncoSec
Below is Scrip’s monthly roundup, including information from Strategic Transactions , of recent technology transfer agreements between companies and academic or other research institutions. Mustan
Unmet medical need and market size continue to drive venture investors to ophthalmic drug plays focused on diseases that blind. This interest is fueled by a stable pool of acquirers and the ability to
Pharmaceuticals BioLineRx Ltd. Hebrew University Yissum Research Development Co. Ltd. BioLineRx gets rights to BL7040 from Hebrew University Hebrew University 's Yissum Research Development Co. Ltd